@forrestfield and Team IAM
We been waiting 9 months for this long-overdue, snail-paced sp adjustment.
Well done!
Lets see if Mr Market will pay up to
a) 7.5c = $100m, before any news flow.
or
b) 11c = $130m , Kogan's
If there is sign of any solid revenue, or small profit or quality news, then
c) Use your calculators
Lets supply dry up !
----------------------
Old timers have seen this before
@T Brown
Fyi:
i think it all depends on
a) Deals,
b) Number of FPPractices in the book,
c) How close we are to M1 ($1m).
M1 to M4
* $1m+3m+7m+(10m+20m) = $41m , Npat
CEO MUST deliver >$40m total,
before 30June 2019,
in 30 months time,
ie
He has to deliver almost every 6 month, to achieve each target.
------------------------------------------
Here are some 'What if scenarios':
i have deliberate used very low PEs of Kogan's 62,
(Class1, Freelancer, Aconex are valued at PE 80 to 120)
Adjust them and do the maths.
18952641
18920655
18925056
Also check the last two SRT threads for more.
Best wishes
Cheers
G
--------
Dyor
Aimo
- Forums
- ASX - By Stock
- CF1
- IAM journey ahead
IAM journey ahead, page-223
-
- There are more pages in this discussion • 776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CF1 (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $15.33M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $1.656K | 63.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 335344 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 280000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 335344 | 0.025 |
2 | 543750 | 0.024 |
1 | 75000 | 0.023 |
1 | 250000 | 0.021 |
1 | 103307 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 280000 | 1 |
0.030 | 500000 | 1 |
0.040 | 100000 | 1 |
0.044 | 500000 | 1 |
0.060 | 17225 | 1 |
Last trade - 15.29pm 15/07/2024 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online